Related Experiment Video
Updated: May 9, 2026

07:50
Establishment of a Clinic-based Biorepository
Published on: May 29, 2017
FGFR2 signaling underlies p63 oncogenic function in squamous cell carcinoma
Matthew R Ramsey1, Catherine Wilson, Benjamin Ory
1Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts, USA.
The Journal of Clinical Investigation
|July 23, 2013
Summary
Squamous cell carcinoma (SCC) relies on the transcription factor p63 for survival. Targeting p63-driven FGFR2 signaling with AZD4547 effectively regresses established SCC tumors, offering a new therapeutic strategy.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genetics
Background:
- Oncogenic transcription factors are key drivers of human cancers.
- Squamous cell carcinoma (SCC) outcomes have seen limited improvement due to poor understanding of its molecular pathogenesis.
- SCCs often overexpress the p53-related transcription factor p63.
Purpose of the Study:
- To investigate the function of p63 in SCC pathogenesis.
- To identify key transcriptional programs regulated by p63 in SCC.
- To explore therapeutic targeting of p63-driven pathways in SCC.
Main Methods:
- Development of an in vivo murine tumor model for SCC.
- Acute genetic ablation of p63 in established, invasive SCC.
- In vivo genome-wide gene expression analysis.
- Inhibition of FGFR2 signaling using the clinical inhibitor AZD4547.
Main Results:
- Established SCCs are critically dependent on p63.
- p63 ablation led to rapid tumor regression and apoptosis.
- A p63-regulated tumor-survival program involving FGFR2 signaling was identified.
- Paracrine FGFR2 signaling, activated by stromal ligands, supports SCC growth.
- AZD4547 demonstrated therapeutic efficacy against endogenous SCCs.
Conclusions:
- p63 plays an essential role in SCC survival and progression.
- p63-driven paracrine FGFR2 signaling is an "addicting" pathway in SCC.
- Targeting the p63-FGFR2 axis represents a promising therapeutic strategy for SCC.
Related Concept Videos
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Negative Regulator Molecules
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
